TY - JOUR
T1 - Tailored versus standard hydration to prevent acute kidney injury after percutaneous coronary intervention
T2 - Network meta-analysis
AU - Moroni, Francesco
AU - Baldetti, Luca
AU - Kabali, Conrad
AU - Briguori, Carlo
AU - Maioli, Mauro
AU - Toso, Anna
AU - Brilakis, Emmanouil S.
AU - Gurm, Hitinder S.
AU - Bagur, Rodrigo
AU - Azzalini, Lorenzo
N1 - Funding Information:
Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), Cardiovascular Systems, Inc (CSI), Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex and research support from Regeneron and Siemens and is a shareholder of Minneapolis Heart Institute (MHI) Ventures. Dr Gurm reports consulting honoraria from Osprey Medical and research funding from the National Institutes of Health Center for Accelerated Innovation and Blue Cross Blue Shield of Michigan. Dr Azzalini received honoraria from Teleflex, Abiomed, Asahi Intecc, Abbott Vascular, Philips and Cardiovascular Systems Inc.
Publisher Copyright:
© 2021 The Authors.
PY - 2021/7/6
Y1 - 2021/7/6
N2 - BACKGROUND: Contrast-induced acute kidney injury (CI-AKI) is a serious complication after percutaneous coronary intervention. The mainstay of CI-AKI prevention is represented by intravenous hydration. Tailoring infusion rate to patient volume status has emerged as advantageous over fixed infusion-rate hydration strategies. METHODS AND RESULTS: A systematic review and network meta-analysis with a frequentist approach were conducted. A total of 8 randomized controlled trials comprising 2312 patients comparing fixed versus tailored hydration strategies to prevent CIAKI after percutaneous coronary intervention were included in the final analysis. Tailored hydration strategies included urine flow rate-guided, central venous pressure-guided, left ventricular end-diastolic pressure-guided, and bioimpedance vector analysis-guided hydration. Primary endpoint was CI-AKI incidence. Safety endpoint was incidence of pulmonary edema. Urine flow rate-guided and central venous pressure-guided hydration were associated with a lower incidence of CI-AKI compared with fixed-rate hydration (odds ratio [OR], 0.32 [95% CI, 0.19-0.54] and OR, 0.45 [95% CI, 0.21-0.97]). No significant difference in pulmonary edema incidence was observed between the different hydration strategies. P score analysis showed that urine flow rate-guided hydration is advantageous in terms of both CI-AKI prevention and pulmonary edema incidence when compared with other approaches. CONCLUSIONS: Currently available hydration strategies tailored on patients’ volume status appear to offer an advantage over guideline-supported fixed-rate hydration for CI-AKI prevention after percutaneous coronary intervention. Current evidence suggests that urine flow rate-guided hydration as the most convenient strategy in terms of effectiveness and safety.
AB - BACKGROUND: Contrast-induced acute kidney injury (CI-AKI) is a serious complication after percutaneous coronary intervention. The mainstay of CI-AKI prevention is represented by intravenous hydration. Tailoring infusion rate to patient volume status has emerged as advantageous over fixed infusion-rate hydration strategies. METHODS AND RESULTS: A systematic review and network meta-analysis with a frequentist approach were conducted. A total of 8 randomized controlled trials comprising 2312 patients comparing fixed versus tailored hydration strategies to prevent CIAKI after percutaneous coronary intervention were included in the final analysis. Tailored hydration strategies included urine flow rate-guided, central venous pressure-guided, left ventricular end-diastolic pressure-guided, and bioimpedance vector analysis-guided hydration. Primary endpoint was CI-AKI incidence. Safety endpoint was incidence of pulmonary edema. Urine flow rate-guided and central venous pressure-guided hydration were associated with a lower incidence of CI-AKI compared with fixed-rate hydration (odds ratio [OR], 0.32 [95% CI, 0.19-0.54] and OR, 0.45 [95% CI, 0.21-0.97]). No significant difference in pulmonary edema incidence was observed between the different hydration strategies. P score analysis showed that urine flow rate-guided hydration is advantageous in terms of both CI-AKI prevention and pulmonary edema incidence when compared with other approaches. CONCLUSIONS: Currently available hydration strategies tailored on patients’ volume status appear to offer an advantage over guideline-supported fixed-rate hydration for CI-AKI prevention after percutaneous coronary intervention. Current evidence suggests that urine flow rate-guided hydration as the most convenient strategy in terms of effectiveness and safety.
KW - Contrast-induced acute kidney injury
KW - Coronary angiography
KW - Hydration
KW - Percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=85110082444&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85110082444&partnerID=8YFLogxK
U2 - 10.1161/JAHA.121.021342
DO - 10.1161/JAHA.121.021342
M3 - Article
C2 - 34169747
AN - SCOPUS:85110082444
SN - 2047-9980
VL - 10
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 13
M1 - e021342
ER -